UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Influence of mRNA expression of epiregulin and amphiregulin on outcome of patients with metastatic colorectal cancer treated with 5‐FU/LV plus irinotecan or irinotecan plus oxaliplatin as first‐line treatment (FIRE 1‐trial)

International journal of cancer, 2016-02, Vol.138 (3), p.739-746

2016

Volltextzugriff (PDF)

Changes over time in the course of advanced pancreatic cancer treatment with systemic chemotherapy: a pooled analysis of five clinical trials from two decades of the German AIO study group

ESMO open, 2024-04, Vol.9 (4), p.102944, Article 102944

2024

Volltextzugriff (PDF)

Second-line chemotherapy with pemetrexed after gemcitabine failure in patients with advanced pancreatic cancer: a multicenter phase II trial

Annals of oncology, 2007-04, Vol.18 (4), p.745-751

2007

Volltextzugriff (PDF)

A phase II study of paclitaxel, weekly, 24-hour continuous infusion 5-fluorouracil, folinic acid and cisplatin in patients with advanced gastric cancer

British journal of cancer, 2000-08, Vol.83 (4), p.458-462

2000

Volltextzugriff (PDF)

SO-6 Changes in the course of advanced pancreatic cancer treatment with systemic chemotherapy: A pooled analysis of five clinical trials from two decades of clinical research within the German AIO Study-Group

Annals of oncology, 2023-06, Vol.34, p.S164-S164

2023

Volltextzugriff (PDF)

Kolorektale gemischte adenoneuroendokrine Karzinome (MANEC) – eine interdisziplinäre diagnostische und therapeutische Herausforderung

Zentralblatt für Chirurgie, 2016, Vol.141 (4)

2016

Volltextzugriff (PDF)

Der Einfluss von Everolimus auf das Outcome fortgeschrittener neuroendokriner Neoplasien – multizentrische Ergebnisse des deutschen NET-Registers

Zeitschrift für Gastroenterologie, 2015, Vol.53 (8)

2015

Volltextzugriff (PDF)

Der Stellenwert der Temozolomid-basierten Chemotherapie in gastroenteropankreatischen und bronchopulmonalen NEN in einer multizentrischen Analyse des Deutschen NET-Registers

Zeitschrift für Gastroenterologie, 2015, Vol.53 (8)

2015

Volltextzugriff (PDF)

Phase II study of weekly paclitaxel plus 24-h continuous infusion 5-fluorouracil, folinic acid and 3-weekly cisplatin for the treatment of patients with advanced gastric cancer

Anti-cancer drugs, 2002-06, Vol.13 (5), p.497-503

2002

Volltextzugriff (PDF)

Solid-pseudopapilläre Neoplasie des Pankreas bei einer 19-jährigen Patientin – eine seltene Tumorentität

Zeitschrift für Gastroenterologie, 2012, Vol.50 (8)

2012

Volltextzugriff (PDF)

Protracted infusional 5-fluorouracil plus high-dose folinic acid combined with bolus mitomycin C in patients with gastrointestinal cancer: a phase I II dose escalation study

British journal of cancer, 2003-12, Vol.89 (11), p.2051-2056

2003

Volltextzugriff (PDF)

A Multicentre Phase II Study of Docetaxel plus Cisplatin for the Treatment of Advanced Gastric Cancer

Chemotherapy (Basel), 2007-01, Vol.53 (6), p.454-460

2007

Volltextzugriff (PDF)

Influence of m RNA expression of epiregulin and amphiregulin on outcome of patients with metastatic colorectal cancer treated with 5‐ FU/LV plus irinotecan or irinotecan plus oxaliplatin as first‐line treatment ( FIRE 1‐trial)

International journal of cancer, 2016-02, Vol.138 (3), p.739-746

2016

Volltextzugriff (PDF)

Die WHO-Klassifikation 2010 und ihr Stellenwert als prognostischer Markern in gastrointestinalen neuroendokrinen Tumoren des deutschen NET-Registers

Zeitschrift für Gastroenterologie, 2011, Vol.49 (8)

2011

Volltextzugriff (PDF)

599P - Early Tumor Shrinkage (ETS) For the Prediction of Efficacy in Metastatic Colorectal Cancer (MCRC): Post-Hoc Analysis from an Irinotecan-Based Randomized First-Line Trial

Annals of oncology, 2012-09, Vol.23, p.ix204-ix204

2012

Volltextzugriff (PDF)

Early Tumor Shrinkage (ETS) For the Prediction of Efficacy in Metastatic Colorectal Cancer (MCRC): Post-Hoc Analysis from an Irinotecan-Based Randomized First-Line Trial

Annals of oncology, 2012-09, Vol.23, p.ix204

2012

Volltextzugriff (PDF)

Mitomycin C continuous infusion as salvage chemotherapy in pretreated patients with advanced gastric cancer

Anti-cancer drugs, 1999-09, Vol.10 (8), p.729-734

1999

Volltextzugriff (PDF)

Die Behandlung fortgeschrittener neuroendokriner Neoplasien mit Sunitinib – Ergebnisse einer retrospektiven, multizentrischen Analyse von Routinedaten des Deutschen NET-Registers

Zeitschrift für Gastroenterologie, 2015-08, Vol.53 (8)

2015

Volltextzugriff (PDF)

Comparison of the tumor associated proteases cathepsin D (CATH D) and urokinase-type plasminogen activator (uPA) in cytosols of human breast cancer patients

Anticancer research, 1999-07, Vol.19 (4A), p.2571

1999

Volltextzugriff (PDF)

Paclitaxel and weekly 24-hour infusion of 5-fluorouracil/folinic acid in advanced gastric cancer

Seminars in oncology, 1997-12, Vol.24 (6 Suppl 19), p.S19

1997

Volltextzugriff (PDF)

A phase II pilot trial with RP101 in advanced pancreatic carcinoma

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.14000-14000

2006

Volltextzugriff (PDF)

Prevalence, awareness and treatment of hypercholesterolaemia in 32 populations: results from the WHO MONICA Project

International journal of epidemiology, 2005-02, Vol.34 (1), p.181-192

2005

Volltextzugriff (PDF)

Docetaxel-cisplatin (DC) versus 5-fluorouracil-leucovorin-cisplatin (FLC) as first-line treatment for locally advanced or metastatic gastric cancer: Preliminary results of a phase III study

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.4512-4512

2008

Volltextzugriff (PDF)

RP101 improves the efficacy of gemcitabine in treating pancreatic carcinoma

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.14075-14075

2006

Volltextzugriff (PDF)

Second-line therapy with pemetrexed after gemcitabine failure in patients with unresectable locally advanced or metastatic pancreatic cancer: A multicenter phase II trial

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.4124-4124

2006

Volltextzugriff (PDF)

1 – 25 von 51

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(45)
Tagungsberichte
(6)

Sprache

Englisch
(32)
Deutsch
(19)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(26)
Male
(19)
Life Sciences & Biomedicine
(18)
Science & Technology
(18)
Female
(16)
Middle Aged
(16)
Adult
(13)
Aged
(12)
Oncology
(11)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(10)
Biological And Medical Sciences
(8)
Medical Sciences
(8)
Stomach Neoplasms - Drug Therapy
(6)
Leucovorin - Administration & Dosage
(5)
Treatment Outcome
(5)
Tumors
(5)
Chemotherapy
(4)
Drug Administration Schedule
(4)
Fluorouracil - Administration & Dosage
(4)
Gastric Cancer
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Influence of mRNA expression of epiregulin and amphiregulin on outcome of patients with metastatic colorectal cancer treated with 5‐FU/LV plus irinotecan or irinotecan plus oxaliplatin as first‐line treatment (FIRE 1‐trial)

Changes over time in the course of advanced pancreatic cancer treatment with systemic chemotherapy: a pooled analysis of five clinical trials from two decades of the German AIO study group

Second-line chemotherapy with pemetrexed after gemcitabine failure in patients with advanced pancreatic cancer: a multicenter phase II trial

A phase II study of paclitaxel, weekly, 24-hour continuous infusion 5-fluorouracil, folinic acid and cisplatin in patients with advanced gastric cancer

SO-6 Changes in the course of advanced pancreatic cancer treatment with systemic chemotherapy: A pooled analysis of five clinical trials from two decades of clinical research within the German AIO Study-Group

Kolorektale gemischte adenoneuroendokrine Karzinome (MANEC) – eine interdisziplinäre diagnostische und therapeutische Herausforderung

Der Einfluss von Everolimus auf das Outcome fortgeschrittener neuroendokriner Neoplasien – multizentrische Ergebnisse des deutschen NET-Registers

Der Stellenwert der Temozolomid-basierten Chemotherapie in gastroenteropankreatischen und bronchopulmonalen NEN in einer multizentrischen Analyse des Deutschen NET-Registers

Phase II study of weekly paclitaxel plus 24-h continuous infusion 5-fluorouracil, folinic acid and 3-weekly cisplatin for the treatment of patients with advanced gastric cancer

Solid-pseudopapilläre Neoplasie des Pankreas bei einer 19-jährigen Patientin – eine seltene Tumorentität

Protracted infusional 5-fluorouracil plus high-dose folinic acid combined with bolus mitomycin C in patients with gastrointestinal cancer: a phase I II dose escalation study

A Multicentre Phase II Study of Docetaxel plus Cisplatin for the Treatment of Advanced Gastric Cancer

Influence of m RNA expression of epiregulin and amphiregulin on outcome of patients with metastatic colorectal cancer treated with 5‐ FU/LV plus irinotecan or irinotecan plus oxaliplatin as first‐line treatment ( FIRE 1‐trial)

Die WHO-Klassifikation 2010 und ihr Stellenwert als prognostischer Markern in gastrointestinalen neuroendokrinen Tumoren des deutschen NET-Registers

599P - Early Tumor Shrinkage (ETS) For the Prediction of Efficacy in Metastatic Colorectal Cancer (MCRC): Post-Hoc Analysis from an Irinotecan-Based Randomized First-Line Trial

Early Tumor Shrinkage (ETS) For the Prediction of Efficacy in Metastatic Colorectal Cancer (MCRC): Post-Hoc Analysis from an Irinotecan-Based Randomized First-Line Trial

Mitomycin C continuous infusion as salvage chemotherapy in pretreated patients with advanced gastric cancer

Die Behandlung fortgeschrittener neuroendokriner Neoplasien mit Sunitinib – Ergebnisse einer retrospektiven, multizentrischen Analyse von Routinedaten des Deutschen NET-Registers

Comparison of the tumor associated proteases cathepsin D (CATH D) and urokinase-type plasminogen activator (uPA) in cytosols of human breast cancer patients

Paclitaxel and weekly 24-hour infusion of 5-fluorouracil/folinic acid in advanced gastric cancer

A phase II pilot trial with RP101 in advanced pancreatic carcinoma

Prevalence, awareness and treatment of hypercholesterolaemia in 32 populations: results from the WHO MONICA Project

Docetaxel-cisplatin (DC) versus 5-fluorouracil-leucovorin-cisplatin (FLC) as first-line treatment for locally advanced or metastatic gastric cancer: Preliminary results of a phase III study

RP101 improves the efficacy of gemcitabine in treating pancreatic carcinoma

Second-line therapy with pemetrexed after gemcitabine failure in patients with unresectable locally advanced or metastatic pancreatic cancer: A multicenter phase II trial

Suchergebnisse filtern